Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps

NCT02024659 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.

NCT NCT02024659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02024659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
Lead sponsor
Beijing Tongren Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2010
Completion date
January 31, 2014
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasal polyps